These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4551961)

  • 21. A novel influenza A (H1N1) vaccine in various age groups.
    Zhu FC; Wang H; Fang HH; Yang JG; Lin XJ; Liang XF; Zhang XF; Pan HX; Meng FY; Hu YM; Liu WD; Li CG; Li W; Zhang X; Hu JM; Peng WB; Yang BP; Xi P; Wang HQ; Zheng JS
    N Engl J Med; 2009 Dec; 361(25):2414-23. PubMed ID: 19846844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Field trial of influenza virus hemagglutinin vaccine (author's transl)].
    Kimura Y
    Fukuoka Igaku Zasshi; 1975 May; 66(5):321-42. PubMed ID: 1236825
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
    Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
    Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses.
    Laver WG; Downie JC; Webster RG
    J Immunol; 1976 Feb; 116(2):336-41. PubMed ID: 55438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza: antigenic spectrum.
    Pereira HG
    Prog Med Virol; 1969; 11():46-79. PubMed ID: 4906872
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on vaccination of infants against influenza with influenza hemagglutinin.
    Hennessy AV; Davenport FM
    Proc Soc Exp Biol Med; 1974 May; 146(1):200-4. PubMed ID: 4827250
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.
    Pépin S; Donazzolo Y; Jambrecina A; Salamand C; Saville M
    Vaccine; 2013 Nov; 31(47):5572-8. PubMed ID: 24016810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the antigenic differences between influenza type A2 virus strains.
    Tokuda M; Bolli P; Imai J
    Acta Sch Med Univ Kioto; 1970 Mar; 40(3):239-53. PubMed ID: 5447689
    [No Abstract]   [Full Text] [Related]  

  • 30. Serological response of chickens, rabbits and guinea-pigs to equine influenza vaccines.
    Frerichs GN; Frerichs CC
    Res Vet Sci; 1973 Mar; 14(2):187-93. PubMed ID: 4805140
    [No Abstract]   [Full Text] [Related]  

  • 31. [Persistence of anti-V hemagglutination-inhibiting antibodies and complement-fixing antibodies induced by administration of inactivated influenza vaccines].
    Profeta ML
    Ann Sclavo; 1972; 14(2):145-58. PubMed ID: 4669354
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhancement of hemagglutination inhibition by complement.
    Reno PW; Hoffmann EM
    Infect Immun; 1972 Dec; 6(6):945-51. PubMed ID: 4674079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactions of antibodies with surface antigens of influenza virus.
    Webster RG; Laver WG; Kilbourne ED
    J Gen Virol; 1968 Dec; 3(3):315-26. PubMed ID: 5711432
    [No Abstract]   [Full Text] [Related]  

  • 35. Respiratory virus vaccines. 3. Pentavalent respiratory syncytial-parainfluenza-mycoplasma pneumoniae vaccine.
    Sweet BH; Tytell AA; Potash L; Weibel RE; Stokes J; Drake ME; Woodhour AF; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):340-9. PubMed ID: 4288342
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.
    Aichinger G; Grohmann-Izay B; van der Velden MV; Fritsch S; Koska M; Portsmouth D; Hart MK; El-Amin W; Kistner O; Barrett PN
    Clin Vaccine Immunol; 2015 Jan; 22(1):46-55. PubMed ID: 25355797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.
    Plennevaux E; Sheldon E; Blatter M; Reeves-Hoché MK; Denis M
    Lancet; 2010 Jan; 375(9708):41-8. PubMed ID: 20018365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody against influenza A2 virus neuraminidase in human sera.
    Schild GC
    J Hyg (Lond); 1969 Jun; 67(2):353-65. PubMed ID: 5256462
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
    Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.